Liver cancer is the sixth most common cancer in the world, with more than 900,000 new cases every year, and a fatality rate that ranks third among all cancers. Recently, the Li Ka Shing faculty of medicine of the University of Hong Kong (HKU) released the world’s first comprehensive treatment plan for intermediate liver cancer, called the “Reduce and Remove” program.
Clinical studies have shown that for intermediate liver cancer that cannot be removed by surgery, nearly 50 percent of patients can achieve a radical curing effect through the comprehensive treatment plan of “Reduce and Remove.” The research results have been published in the Dec. 2022 edition of The Lancet Gastroenterology and Hepatology….